Risk-Adapted Therapy of Acute Myeloid Leukemia of Adults (18-60 Years) According to the Cytogenetic Result
Latest Information Update: 09 Nov 2021
At a glance
- Drugs Tretinoin (Primary) ; Cytarabine; Etoposide; Idarubicin
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
Most Recent Events
- 06 Dec 2016 Results assessing minimal residual disease monitoring in Acute Myeloid Leukemia study group (AML HD93, NCT00146120, NCT00151255, NCT00151242, NCT00850382 and NCT02013648 trials) presented at the 58th Annual Meeting and Exposition of the American Society of Hematology
- 02 Jul 2008 New trial record.